Skip to content

News
Contact Us
Linkedin

Home
About Us
- Executive Team
Cycloset
Pipeline
- Cycloset for Pediatric T2DM Patients
- VS41157 for Pancreatic Cancer
Technologies
Therapeutic Areas
- Metabolic Diseases
- Immunological Disorders
Partners & Collaborators
Publications

Creators of Cycloset^®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info

Veroscience > News > Archives

Share
Print

Archives

March 28-31, 2017 Orlando, FL

Endocrine Society 99th Annual Meeting

www.endocrine.org/endo-2017

Read More

March 28-31, 2017 Chicago, IL

Endocrine Society 100th Annual Meeting

www.endocrine.org/endo-2018

Read More

February 3-5, 2017 Ft. Lauderdale, FL

Pri-Med South Annual Conference

www.pri-med.com/medical-conferences/2017/annual-conference-south.aspx

Read More

June 10-14, 2016 New Orleans

American Diabetes Association (with Valeant)

professional.diabetes.org/meeting/scientific-sessions/76th-scientific-sessions

Read More

May 26-29, 2016 Ponte Vedra Beach, FL

31st Annual Clinical Conference on Diabetes

professional.diabetes.org/meeting/other/30th-annual-clinical-conference-diabetes

Read More

May 7, 2016 Atlanta, GA

Cardiometabolic Health Congress Regional Conference Series

Read More

May 6, 2016 Cleveland, OH

Cleveland Clinic 21st Annual Diabetes Day

www.clevelandclinicmeded.com/live/courses/diabetesday/default.asp

Read More

August 27, 2015

Can deconstructing the biological clock help treat diabetes and cancer?

medcitynews.com/2015/08/can-deconstructing-the-biological-clock-help-treat-diabetes-and-cancer/comment-page-1/

Read More

June 15, 2015

Two Peer-Reviewed Studies Focusing on Unique Therapeutic Impact of VeroScience’s Cycloset Recently Published in Journal of Diabetes Research

www.prnewswire.com/news-releases/two-peer-reviewed-studies-focusing-on-unique-therapeutic-impact-of-verosciences-cycloset-recently-published-in-journal-of-diabetes-research-300098977.html

Read More

May 2, 2013

Cycloset (bromocriptine mesylate) Included in American Association of Clinical Endocrinologists Comprehensive Diabetes Management Algorithm

Cycloset is recommended for dual therapy for patients with entry HbA1c ≥ 7.5% SAN DIEGO & TIVERTON, R.I. --(BUSINESS WIRE)--...

Read More

« Previous 1 2 3 Next »

News
Archives
Visit www.cycloset.com for
more information on the product

About Us
Executive Team

Cycloset
Cycloset Clinical Profile
Mechanism of Action
Pre-Clinical Studies
Clinical Studies
U.S. Cycloset Patents
www.cycloset.com

Pipeline
Cycloset for Pediatric T2DM Patients
VS41157 for Pancreatic Cancer

Technologies
Circadian Neuroendocrine Resetting Therapy (CNRT)
CNRT Overview Video References
Photo Immuno-Resetting Therapy for the Treatment of Cancer

Therapeutic Areas
Metabolic Diseases
Immunological Disorders

Partners & Collaborators
News
Publications
Contact Us
Site Map
Terms of Use

Website by Axxiem

© Copyright . All Right Reserved

By accessing our website or software provided by our third-party vendors, you consent to accept cookies, (including other identifiers). These include pieces of text that are stored on your computer or device. This site uses cookies and Google Analytics to improve navigation, minimize the need to reenter information previously entered on forms, personalize messages, and collect statistical information to improve site navigation and provide content of greatest interest to users.

Cookie settings ACCEPT

Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT